Sermorelin

Research Guide · Laboratory Use Only

GHRH analog

Sermorelin is GHRH(1–29), the shortest fully active fragment of growth-hormone-releasing hormone. It is one of the most historically studied GHRH analogs.

What it is

Sermorelin binds the GHRH receptor to prompt the pituitary to synthesize and release growth hormone. Its short half-life makes it a useful reference tool in studies of the natural, pulsatile pattern of GH secretion.

How it’s studied

Research interest centers on the GH/IGF-1 axis and on how a short-acting GHRH analog compares with longer-acting ones such as CJC-1295 and stabilized analogs like Tesamorelin.

Research focus areas

  • Native-like GHRH-receptor activation
  • Pulsatile GH secretion as a research model
  • Comparisons across GHRH analogs
  • GH/IGF-1 axis signaling

Handling & documentation

In the laboratory this material is typically supplied as a lyophilized (freeze-dried) powder and reconstituted with bacteriostatic or sterile water for in-vitro work. As with any research compound, the quality signal that matters most is a lot-specific Certificate of Analysis (COA) from an independent lab, confirming identity by mass spectrometry and purity by HPLC. Store per the supplier’s guidance and verify the COA before use.

Browse the COA-verified research catalog →

For laboratory research use only. This content is educational and written for a research context. The compound is a research-use-only (RUO) material — not a drug, supplement, food, or cosmetic, not for human or veterinary use, and no claims are made to diagnose, treat, cure, or prevent any condition. No dosing or protocols are provided.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *